Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.485 USD | -2.29% | +14.75% | -81.53% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- Trading Ideas